TELADOC HEALTH, INC. (TDOC) FY2026 YTD Q3 Statement of Cash Flows

Published Source: Form 10-Q on SEC EDGAR filed (opens in a new tab)

2026-01-01 to 2026-09-30

Statement of Cash Flows

Swipe to see the full flow
TELADOC HEALTH, INC. cash flow reconciliation, Jan 1, 2026 through Sep 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Orange marks positive customer-advance and deferred-revenue changes that add to operating cash in the reconciliation. These are net changes, not gross customer receipts. Negative changes are neutral reconciliation adjustments; they do not by themselves identify cash payments. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Amortization of intangible assets → operating reconciliation: $266,554,000.00Accrued expenses and other current liabilities → operating reconciliation: $51,066,000.00Stock-based compensation → operating reconciliation: $35,528,000.00Depreciation of property and equipment → operating reconciliation: $7,115,000.00Inventory → operating reconciliation: $6,113,000.00Amortization of right-of-use assets → operating reconciliation: $5,006,000.00Other, net → operating reconciliation: $4,279,000.00Other assets → operating reconciliation: $4,022,000.00Provision for allowances for doubtful accounts → operating reconciliation: $1,176,000.00Deferred revenue → operating reconciliation: $429,000.00operating reconciliation → Net cash from operating activities: $180,636,000.00operating reconciliation → Net loss: $129,679,000.00operating reconciliation → Accounts receivable: $38,958,000.00operating reconciliation → Accrued compensation: $15,806,000.00operating reconciliation → Prepaid expenses and other current assets: $7,289,000.00operating reconciliation → Operating lease liabilities: $6,677,000.00operating reconciliation → Deferred income taxes: $1,535,000.00operating reconciliation → Accounts payable: $694,000.00operating reconciliation → Other liabilities: $14,000.00Other, net → investing reconciliation: $3,000.00investing reconciliation → Capitalized software development costs: $91,460,000.00investing reconciliation → Asset acquisition resulting in net intangible assets: $12,675,000.00investing reconciliation → Capital expenditures: $3,802,000.00investing reconciliation → Payments for investments: $1,000,000.00Net cash used in financing activities → financing reconciliation: $1,157,000.00Proceeds from employee stock purchase plan → financing reconciliation: $1,654,000.00Proceeds from the exercise of stock options → financing reconciliation: $37,000.00financing reconciliation → Other, net: $2,848,000.00Net cash used in investing activities → investing reconciliation: $108,934,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $781,084,000.00Net cash from operating activities → Cash sources and uses: $180,636,000.00Cash sources and uses → Exchange-rate effect: $1,720,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $849,909,000.00Cash sources and uses → Net cash used in investing activities: $108,934,000.00Cash sources and uses → Net cash used in financing activities: $1,157,000.00Net loss: -$129,679,000.00Net loss−$129.68 MGoodwill impairment: $0.00Amortization of intangible assets: $266,554,000.00Intangible amortization+$266.55 MStock-based compensation: $35,528,000.00Stock-based compensation+$35.53 MDepreciation of property and equipment: $7,115,000.00Depreciation expense+$7.12 MAmortization of right-of-use assets: $5,006,000.00Operating lease amortization+$5.01 MProvision for allowances for doubtful accounts: $1,176,000.00Credit loss provision+$1.18 MDeferred income taxes: -$1,535,000.00Deferred taxes & credits−$1.54 MOther, net: $4,279,000.00Other non-cash items+$4.28 MAccounts receivable: -$38,958,000.00Accounts receivable−$38.96 MPrepaid expenses and other current assets: -$7,289,000.00Prepaid & other assets−$7.29 MInventory: $6,113,000.00Inventories+$6.11 MOther assets: $4,022,000.00Other operating assets+$4.02 MAccounts payable: -$694,000.00Accounts payable−$694.00 KAccrued expenses and other current liabilities: $51,066,000.00Accrued expenses and other current liabilities+$51.07 MAccrued compensation: -$15,806,000.00Accrued compensation−$15.81 MDeferred revenue: $429,000.00Deferred revenue+$429.00 KOperating lease liabilities: -$6,677,000.00Operating lease liabilities−$6.68 MOther liabilities: -$14,000.00Other noncurrent liabilities−$14.00 KNet cash from operating activities: $180,636,000.00Operating cash+$180.64 Moperating reconciliation: $381,288,000.00Proceeds from the exercise of stock options: $37,000.00Stock option exercises+$37.00 KProceeds from employee stock purchase plan: $1,654,000.00Stock plan proceeds+$1.65 MOther, net: -$2,848,000.00Other financing, net−$2.85 MRepayment of convertible senior notes: $0.00Payment of credit facility issuance costs: $0.00Net cash used in financing activities: -$1,157,000.00. Cash required to fund net payments.Financing cash−$1.16 Mfinancing reconciliation: $2,848,000.00Capital expenditures: -$3,802,000.00PP&E purchases−$3.80 MCapitalized software development costs: -$91,460,000.00Software spending−$91.46 MProceeds from the sale of investment: $0.00Acquisitions accounted for as business combinations, net of cash acquired: $0.00Payments for investments: -$1,000,000.00Investment purchases−$1.00 MAsset acquisition resulting in net intangible assets: -$12,675,000.00Intangible asset purchases−$12.68 MOther, net: $3,000.00Other investing, net+$3.00 KNet cash used in investing activities: -$108,934,000.00. Cash required to fund net payments.Investing cash−$108.93 Minvesting reconciliation: $108,937,000.00Cash sources and uses: $961,720,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $781,084,000.00Beginning cash$781.08 MEnding cash: Cash, cash equivalents, and restricted cash: $849,909,000.00Ending cash$849.91 MExchange-rate effect: -$1,720,000.00FX effect−$1.72 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsNet loss −$129.68M + net operating adjustments $310.32M = operating cash +$180.64MFree cash flow$176.83 MOperating cash − cash spent on PP&ECash flow / Net incomeNot meaningfulOperating cash flow ÷ net incomeNet cash change+$68.83 MEnding cash − beginning cash
Chart details

TELADOC HEALTH, INC. cash flow reconciliation, Jan 1, 2026 through Sep 30, 2026

Cash flows for Jan 1, 2026 through Sep 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Sep 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
781,084,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
180,636,000 US dollars. Net cash provided.
Net loss
negative 129,679,000 US dollars
Goodwill impairment
0 US dollars
Amortization of intangible assets
266,554,000 US dollars
Stock-based compensation
35,528,000 US dollars
Depreciation of property and equipment
7,115,000 US dollars
Amortization of right-of-use assets
5,006,000 US dollars
Provision for allowances for doubtful accounts
1,176,000 US dollars
Deferred income taxes
negative 1,535,000 US dollars
Other, net
4,279,000 US dollars
Accounts receivable
negative 38,958,000 US dollars
Prepaid expenses and other current assets
negative 7,289,000 US dollars
Inventory
6,113,000 US dollars
Other assets
4,022,000 US dollars
Accounts payable
negative 694,000 US dollars
Accrued expenses and other current liabilities
51,066,000 US dollars
Accrued compensation
negative 15,806,000 US dollars
Deferred revenue
429,000 US dollars
Operating lease liabilities
negative 6,677,000 US dollars
Other liabilities
negative 14,000 US dollars
Investing activities
negative 108,934,000 US dollars. Net cash used.
Capital expenditures
negative 3,802,000 US dollars
Capitalized software development costs
negative 91,460,000 US dollars
Proceeds from the sale of investment
0 US dollars
Acquisitions accounted for as business combinations, net of cash acquired
0 US dollars
Payments for investments
negative 1,000,000 US dollars
Asset acquisition resulting in net intangible assets
negative 12,675,000 US dollars
Other, net
3,000 US dollars
Financing activities
negative 1,157,000 US dollars. Net cash used.
Proceeds from the exercise of stock options
37,000 US dollars
Proceeds from employee stock purchase plan
1,654,000 US dollars
Other, net
negative 2,848,000 US dollars
Repayment of convertible senior notes
0 US dollars
Payment of credit facility issuance costs
0 US dollars
Operating adjustment reconciliation
381,288,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
2,848,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
108,937,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 1,720,000 US dollars
Ending cash on Sep 30, 2026
849,909,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
961,720,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
68,825,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
Operating cash flow
180,636,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
3,802,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
176,834,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net loss −$129.68M + net operating adjustments $310.32M = operating cash +$180.64M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 180,636,000 US dollars minus 3,802,000 US dollars equals 176,834,000 US dollars.
TELADOC HEALTH, INC. (TDOC) FY2026 YTD Q3 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!